A Scoping Review of Clinical Guidelines for the Management of Cardiovascular Diseases (CVD) in Pregnancy in Low- and Middle-Income Countries (LMIC)
By: Uma Vasudevan, Preety Rajbangshi and Jane Hirst
References
- World Health Organization. World Health Organization; 2023 [cited 2023 Nov 16]. Maternal mortality. Available from:
https://www.who.int/news-room/fact-sheets/detail/maternal-mortality - Nair M, Nelson-Piercy C, Knight M. Indirect maternal deaths: UK and global perspectives. Obstetric Medicine. 2017;10(1):10–15. DOI: 10.1177/1753495X16689444
- Storm F, Agampodi S, Eddleston M, Sørensen JB, Konradsen F, Rheinländer T. Indirect causes of maternal death. The Lancet Global Health. 2014;2(10):
e566 . DOI: 10.1016/S2214-109X(14)70297-9 - Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy: The Task Force for the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). European Heart Journal. 2018;39(34):3165–3241. DOI: 10.1093/eurheartj/ehy340
- Goldstein SA, Ward CC. Congenital and acquired valvular heart disease in pregnancy. Current Cardiology Report. 2017;19(10):96. DOI: 10.1007/s11886-017-0910-6
- Elkayam U, Goland S, Pieper PG, Silverside CK. High-risk cardiac disease in pregnancy: Part I. Journal of the American College of Cardiology. 2016;68(4):396–410. DOI: 10.1016/j.jacc.2016.05.048
- Silversides CK, Grewal J, Mason J, Sermer M, Kiess M, Rychel V, et al. Pregnancy outcomes in women with heart disease: The CARPREG II study. Journal of the American College of Cardiology. 2018;71(21):2419–2430. DOI: 10.1016/j.jacc.2018.02.076
- Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, et al. Global causes of maternal death: A WHO systematic analysis. The Lancet Global Health. 2014;2(6):e323–e333. DOI: 10.1016/S2214-109X(14)70227-X
- Keepanasseril A, Pfaller B, Metcalfe A, Siu SC, Davis MB, Silversides CK. Cardiovascular deaths in pregnancy: Growing concerns and preventive strategies. Canadian Journal of Cardiology. 2021;37(12): 1969–1978. DOI: 10.1016/j.cjca.2021.09.022
- Gad MM, Elgendy IY, Mahmoud AN, Saad AM, Isogai T, Sande Mathias I, et al. Disparities in cardiovascular disease outcomes among pregnant and post-partum women. Journal of the American Heart Association. 2020;10(1):
e017832 . DOI: 10.1161/JAHA.120.017832 - Shrestha P, Kuikel S, Bajracharya S, Ghimire A, Shrestha R, Mishra A, et al. Pregnancy with heart disease in South Asia: A systematic review and meta-analysis of prevalence and outcome. Annals of Medicine and Surgery (London). 2022;80:104293. DOI: 10.1016/j.amsu.2022.104293
- Lumsden R, Barasa F, Park LP, Ochieng CB, Alera JM, Millar HC, et al. High burden of cardiac disease in pregnancy at a national referral hospital in Western Kenya. Global Heart. 2020;15(1):10. DOI: 10.5334/gh.404
- Gupta N, Gupta S, Lalchandani A, Gupta R, Diwedi S, Singh J. Relationship of degree of anemia as direct or indirect causes of heart failure and its impact on maternal and fetal outcome. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2014;3(4):982–985. DOI: 10.5455/2320-1770.ijrcog20141220
- Sliwa K, Böhm M. Incidence and prevalence of pregnancy-related heart disease. Cardiovascular Research. 2014;101(4):554–560. DOI: 10.1093/cvr/cvu012
- Khalid H, Karishma F, Mumtaz H, Saqib M, Iftikhar M, Shahab R. Current status and future of cardio-obstetrics-review. Annals of Medicine and Surgery (London). 2023;85(6):2774–2780. DOI: 10.1097/MS9.0000000000000773
- Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Medical Research Methodology. 2018;18(1):143. DOI: 10.1186/s12874-018-0611-x
- Peters MD, Godfrey C, McInerney P, Munn Z, Tricco AC, Khalil H.
Scoping reviews . In: Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z, editors. JBI Manual for Evidence Synthesis [Internet]. JBI; 2024 [cited 2024 May 22]. Available from:https://jbi-global-wiki.refined.site/space/MANUAL/355862497/10.+Scoping+reviews - The World Bank. The World Bank. 2022 [cited 2022 Dec 19]. World Bank Country and Lending Groups – World Bank Data Help Desk. Available from:
https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups - WHO. WHO recommendation on calcium supplementation before pregnancy for the prevention of pre-eclampsia and its complications [Internet]. World Health Organization; 2020. Available from:
https://www.who.int/publications/i/item/9789240003118 - WHO. WHO recommendation on calcium supplementation during pregnancy for the prevention of pre-eclampsia and its complications [Internet]. World Health Organization; 2018. Available from:
https://apps.who.int/iris/bitstream/handle/10665/277235/9789241550451-eng.pdf?ua=1 - WHO. WHO recommendations on drug treatment for non-severe hypertension in pregnancy [Internet]. World Health Organization; 2020. Available from:
https://www.who.int/publications/i/item/9789240008793 - WHO. WHO recommendations on drug treatment for severe hypertension in pregnancy [Internet]. World Health Organization; 2018. Available from:
https://apps.who.int/iris/bitstream/handle/10665/277234/9789241550437-eng.pdf?ua=1 - WHO. WHO recommendations on Policy of interventionist versus expectant management of severe pre-eclampsia before term [Internet]. World Health Organization; 2018. Available from:
https://www.who.int/publications/i/item/9789241550444 - World Health Organization. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia [Internet]. World Health Organization; 2011 [cited 2023 Nov 7]. Available from:
https://iris.who.int/handle/10665/44703 - World Health Organization. WHO recommendations on antiplatelet agents for the prevention of pre-eclampsia. World Health Organization; 2021.
- Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. International Journal of Gynaecology & Obstetrics. 2019;145(Suppl 1):1–33. DOI: 10.1002/ijgo.12802
- Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1):24–43. DOI: 10.1161/HYPERTENSIONAHA.117.10803
- Ministry of Health Malaysia, Academy of Medicine Malaysia, National Heart Association of Malaysia. Clinical Practice Guideline Heart Disease in Pregnancy, 2nd edition [Internet]. Ministry of Health Malaysia; 2016. Available from:
https://www.moh.gov.my/moh/resources/Penerbitan/CPG/CARDIOVASCULAR/7.pdf - Moodley J, Soma-Pillay P, Buchmann E, Pattinson RC. Hypertensive disorders in pregnancy: 2019 National guideline. South African Medical Journal. 2019;109(9). Available from:
http://www.samj.org.za/index.php/samj/article/view/12723 - Grupo elaborador de la guía (GEG) – Dirección de Guías de Práctica Clínica, Farmacovigilancia y Tecnovigilancia del Instituto de Evaluación de Tecnologías en Salud e Investigación (IETSI), del Seguro Social de Salud (EsSalud) del Perú. Guía de práctica clínica para la prevención y el manejo de la enfermedad hipertensiva del embarazo. Revista Colombiana de Obstetricia Ginecologia. 2022;73(1):48–61. DOI: 10.18597/rcog.3810
- Hypertensive Disorders in Pregnancy Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association, Hypertensive Disorders in Pregnancy Subgroup Chinese Society of Obstetrics and Gynecology Chinese Medical Association. Diagnosis and treatment guideline of hypertensive disorders in pregnancy (2015). Zhonghua Fu Chan Ke Za Zhi. 2015;50(10):721–728.
- Avila WS, Alexandre ERG, Castro ML de, Lucena AJG de, Marques-Santos C, Freire CMV, et al. Brazilian Cardiology Society statement for management of pregnancy and family planning in women with heart disease – 2020. Arquivos Brasileiros de Cardiologia. 2020;114(5):849–942. DOI: 10.36660/abc.20200406
- Baqai SM, Rahim R, Ala H, Tarar SH, Waqar F, Yasmeen H, et al. Society of Obstetricians and Gynaecologists Pakistan (SOGP) hypertensive disorders in pregnancy guidelines – 2022. Pakistan Armed Force Medical Journal. 2022;72(3):731–753. DOI: 10.51253/pafmj.v72i3.8600
- De Silva PHP, Lanerolle S, Dodampahala SH, Silva R, Mathota C. Hypertensive disorders of pregnancy. Sri Lanka Journal of Obstetrics and Gynaecology. 2022;44(1):65. DOI: 10.4038/sljog.v44i1.8046
- Moodley J, Soma-Pillay P, Buchmann E, Pattinson RC. Hypertensive disorders in pregnancy: 2019 National guideline. South African Medical Journal. 2019;109(9). Available from:
http://www.samj.org.za/index.php/samj/article/view/12723 - Sliwa K, Libhaber E, Elliott C, Momberg Z, Osman A, Z✓hlke L, et al. Spectrum of cardiac disease in maternity in a low-resource cohort in South Africa. Heart. 2014;100(24):1967–1974. DOI: 10.1136/heartjnl-2014-306199
- Soma-Pillay P, Seabe J, Soma-Pillay P, Seabe J, Sliwa K. The importance of cardiovascular pathology contributing to maternal death: Confidential Enquiry into Maternal Deaths in South Africa, 2011–2013. Cardiovascular Journal of Africa. 2016;27(2):60–65. DOI: 10.5830/CVJA-2016-008
- Rakisheva A, Sliwa K, Bauersachs J, Van Linthout S, Chopra VK, Bayes-Genis A, et al. Multidisciplinary care of peripartum heart failure: A scientific statement of the Heart Failure Association of the ESC. European Journal of Heart Failure. 2024;26(4):742–753. DOI: 10.1002/ejhf.3246
- RHDAustralia (ARF/RHD writing group). The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease. Medical Journal of Australia. 2022;214(5):220–227. DOI: 10.5694/mja2.50851
- van der Graaf R, van der Zande ISE, den Ruijter HM, Oudijk MA, van Delden JJM, Oude Rengerink K, et al. Fair inclusion of pregnant women in clinical trials: An integrated scientific and ethical approach. Trials. 2018;19(1):78. DOI: 10.1186/s13063-017-2402-9
- Asalkar M, Shaikh H, Mahadik PV, Shaikh P, Pardeshi A, Wakte SP, et al. Inclusion of pregnant women in clinical trials: Need, ethical and scientific considerations and current status. Journal of South Asian Federation of Obstetrics and Gynaecology. 2024;16(2):126–133. DOI: 10.5005/jp-journals-10006-2401
DOI: https://doi.org/10.5334/gh.1453 | Journal eISSN: 2211-8179
Language: English
Submitted on: Feb 26, 2025
Accepted on: Jul 23, 2025
Published on: Aug 21, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2025 Uma Vasudevan, Preety Rajbangshi, Jane Hirst, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.